Appendix Cancer Sharply Rises Among Gen Xers, Millennials
Though still rare, this cancer is becoming more common — and, experts say, part of a concerning trend.
An analysis of data from the National Cancer Institute published this week in the Annals of Internal Medicine found a sharp rise in appendix cancer (appendiceal adenocarcinoma) cases in the United States, especially among Gen X and millennials.
When looking at nearly 5,000 cases of appendix cancer, researchers noted that cancer incidence among Gen X adults was more than 3 times greater compared with a control group of adults born between 1941 and 1949. For millennials, the cancer rate was 4 times higher compared with the control group.
“It’s concerning that we're seeing appendix cancer rates triple among Gen Xers and quadruple among older millennials,” says lead study author Andreana N. Holowatyj, PhD, an assistant professor of hematology, oncology, and cancer biology at Vanderbilt University Medical Center in Nashville, Tennessee.
“But I also think it's important to emphasize the rarity of this disease overall and not spark any considerable alarm.”
Because cancer has been considered more of an old person’s disease, the recent jump in gastrointestinal cancers among younger adults has been puzzling. Research as to why this is occurring has only recently begun, and so far researchers haven’t identified a clear reason for the trend.
Evidence suggests, however, that these gastrointestinal cancers may share similar modifiable risk factors — such as obesity, poor diet, alcohol consumption, and tobacco use, according to Ardaman Shergill, MD, an oncologist specializing in gastrointestinal cancers at UChicago Medicine.
“I speculate that risk-reducing strategies in other cancers, like not smoking, stopping or at least limiting alcohol, and regular exercise, may have beneficial effects in appendix cancer as well,” says Dr. Shergill, who was not involved in the study.
Holowatyj adds that genetics may also play a role, and her lab is working to better understand how various risk factors may contribute to the disease.
“I'm inspired by all of my patients who have battled appendix cancer and continue to battle appendix cancer as they try and help us understand what's driving disease development and how we can reduce this burden over time,” she says.
Preventing appendix cancer is vital, as this disease can be especially difficult to diagnose in its early stages before the cancer has spread.
“Symptoms of appendix cancer are vague, nonspecific, and often overlap with other gastrointestinal or gynecologic cancers,” says Zachary J. Brown, DO, a surgical oncologist and assistant professor of surgery at the NYU Grossman Long Island School of Medicine in New York.
“Patients may experience nonspecific symptoms such as persistent abdominal pain, fatigue, or unexplained weight loss. As a result of the nonspecific symptoms and not being able to see this cancer on colonoscopy, appendix cancers are often found at a late stage,” Dr. Brown says.
“Often these are long surgeries needing many hours to complete,” says Shergill.
“There is still so much to learn about this disease,” says Brown, who was not involved in the study. “A better understanding of the tumor biology, molecular characteristics as well as definitive risk factors for appendix cancers is essential. This will allow for improved therapies and potential earlier detection.”
©2025 sitename.com All rights reserved